These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7866586)

  • 1. Metabolic disorders in children.
    Morris AA; Turnbull DM
    Curr Opin Neurol; 1994 Dec; 7(6):535-41. PubMed ID: 7866586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
    Ferri R; Chance PF
    Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of X-linked adrenoleukodystrophy with Lorenzo's oil.
    Moser HW
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):279-80. PubMed ID: 10449544
    [No Abstract]   [Full Text] [Related]  

  • 4. Lorenzo's oil therapy of adrenoleukodystrophy.
    DiGregorio VY; Schroeder DJ
    Ann Pharmacother; 1995 Mar; 29(3):312-3. PubMed ID: 7606079
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenoleukodystrophy and the mitochondrial connection: clues for supplementing Lorenzo's oil.
    Moraes CT
    Brain; 2013 Aug; 136(Pt 8):2339-41. PubMed ID: 23842565
    [No Abstract]   [Full Text] [Related]  

  • 6. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive effects with Lorenzo's oil.
    Siva N
    Lancet Neurol; 2005 Sep; 4(9):529. PubMed ID: 16136703
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy.
    Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B
    Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diet therapy in the treatment of neuropediatric disorders].
    Chaves-Carballo E
    Rev Neurol; 2003 Aug 1-15; 37(3):267-74. PubMed ID: 12938059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adrenoleukodystrophy: Lorenzo's Oil].
    Yamawaki T
    Brain Nerve; 2022 Dec; 74(12):1354-1357. PubMed ID: 36503132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
    Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
    Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
    [No Abstract]   [Full Text] [Related]  

  • 12. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil.
    Moser HW; Raymond GV; Lu SE; Muenz LR; Moser AB; Xu J; Jones RO; Loes DJ; Melhem ER; Dubey P; Bezman L; Brereton NH; Odone A
    Arch Neurol; 2005 Jul; 62(7):1073-80. PubMed ID: 16009761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials.
    Moser HW; Raymond GV; Koehler W; Sokolowski P; Hanefeld F; Korenke GC; Green A; Loes DJ; Hunneman DH; Jones RO; Lu SE; Uziel G; Giros ML; Roels F
    Adv Exp Med Biol; 2003; 544():369-87. PubMed ID: 14713253
    [No Abstract]   [Full Text] [Related]  

  • 14. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
    Zinkham WH; Kickler T; Borel J; Moser HW
    N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
    [No Abstract]   [Full Text] [Related]  

  • 15. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More on Lorenzo's oil.
    Odone A; Odone M
    N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
    [No Abstract]   [Full Text] [Related]  

  • 17. Normal natural killer cell activity in a patient with adrenoleukodystrophy treated with Lorenzo's oil.
    Tanaka M; Koike R; Kuwabara T
    Neurodegeneration; 1996 Jun; 5(2):192-4. PubMed ID: 8819141
    [No Abstract]   [Full Text] [Related]  

  • 18. A happier sequel to Lorenzo's Oil?
    Wanders RJ
    Nat Med; 1998 Nov; 4(11):1245-6. PubMed ID: 9809546
    [No Abstract]   [Full Text] [Related]  

  • 19. Lorenzo's oil--hope and disappointment.
    Rizzo WB
    N Engl J Med; 1993 Sep; 329(11):801-2. PubMed ID: 8043042
    [No Abstract]   [Full Text] [Related]  

  • 20. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible?
    Cappa M; Bizzarri C; Giannone G; Aiello C; Di Biase A
    J Endocrinol Invest; 2011 Nov; 34(10):753-6. PubMed ID: 21399389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.